|
|
Previous Article | Table of Contents | Next Article 
Marginal zone B-cell lymphomas of different sites share similar cytogenetic
and morphologic features [see comments]
J Dierlamm, S Pittaluga, I Wlodarska, M Stul, J Thomas, M Boogaerts, L Michaux, A Driessen, C Mecucci and JJ Cassiman
Department of Pathology, University of Leuven, Belgium.
Clinical, histologic, cytogenetic, and molecular genetic data of 31
patients with extranodal, nodal, and splenic marginal zone B-cell lymphoma
(MZBCL) are presented. Despite these variable clinical manifestations, a
similar spectrum of morphologic features as well as distinctive
immunophenotypic findings were noted. In all cases, a monotypic B-cell
proliferation consistently negative for CD5, CD10, and CD23 was found
expanding the marginal zone of the B follicle with and without colonization
of the follicle centers. Clonal chromosomal abnormalities were detected in
23 of the 31 patients. Recurrent aberrations included whole or partial
trisomy 3 (18 cases), trisomy 18 (9 cases), and structural rearrangements
of chromosome 1 with breakpoints in 1q21 (9 cases) or 1p34 (6 cases), all
of which were seen in extranodal, nodal, as well as splenic MZBCL.
Abnormalities of the additional chromosome 3, such as
+del(3)(p13),+i(3)(q10), or structural changes involving the distal part of
the long arm, were evident in 9 of the 18 cases. All recurrent
abnormalities were found in MZBCL more frequently than in other histologic
entities of B-cell non-Hodgkin's lymphoma (B-NHL). None of the known
lymphoma-associated chromosomal changes or rearrangements of the BCL1,
BCL2, BCL3, BCL6, and CMYC genes were detected. We conclude that MZBCL
represent a distinct entity of B- NHL with characteristic morphologic and
immunophenotypic features and particular chromosomal abnormalities, and
that a close histogenetic relationship between extranodal, nodal, and
splenic MZBCL is likely, although the clinical presentation may vary.
Volume 87,
Issue 1,
pp. 299-307,
01/01/1996
Copyright © 1996 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. J. Bende, F. van Maldegem, and C. J.M. van Noesel
Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas
Haematologica,
August 1, 2009;
94(8):
1109 - 1123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Novak, A. Rinaldi, I. Kwee, S. V. Nandula, P. M. V. Rancoita, M. Compagno, M. Cerri, D. Rossi, V. V. Murty, E. Zucca, et al.
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Blood,
May 14, 2009;
113(20):
4918 - 4921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Braggio, J. J. Keats, X. Leleu, S. Van Wier, V. H. Jimenez-Zepeda, R. Valdez, R. F.J. Schop, T. Price-Troska, K. Henderson, A. Sacco, et al.
Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-{kappa}B Signaling Pathways in Waldenstrom's Macroglobulinemia
Cancer Res.,
April 15, 2009;
69(8):
3579 - 3588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kahl and D. Yang
Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL
Hematology,
January 1, 2008;
2008(1):
359 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pfeifer, M. Pantic, I. Skatulla, J. Rawluk, C. Kreutz, U. M. Martens, P. Fisch, J. Timmer, and H. Veelken
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays
Blood,
February 1, 2007;
109(3):
1202 - 1210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ghesquieres, F. Berger, P. Felman, E. Callet-Bauchu, P.-A. Bryon, A. Traverse-Glehen, C. Thieblemont, L. Baseggio, A.-S. Michallet, B. Coiffier, et al.
Clinicopathologic Characteristics and Outcome of Diffuse Large B-Cell Lymphomas Presenting With an Associated Low-Grade Component at Diagnosis
J. Clin. Oncol.,
November 20, 2006;
24(33):
5234 - 5241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. E. Valli, W. Vernau, L.-P de Lorimier, P. S. Graham, and P. F. Moore
Canine Indolent Nodular Lymphoma
Vet. Pathol.,
May 1, 2006;
43(3):
241 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Troen, V. Nygaard, T.-K. Jenssen, I. M. Ikonomou, A. Tierens, E. Matutes, A. Gruszka-Westwood, D. Catovsky, O. Myklebost, G. Lauritzsen, et al.
Constitutive Expression of the AP-1 Transcription Factors c-jun, junD, junB, and c-fos and the Marginal Zone B-Cell Transcription Factor Notch2 in Splenic Marginal Zone Lymphoma
J. Mol. Diagn.,
November 1, 2004;
6(4):
297 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hosokawa, H. Suzuki, Y. Suzuki, R. Takahashi, and M. Seto
Antiapoptotic Function of Apoptosis Inhibitor 2-MALT1 Fusion Protein Involved in t(11;18)(q21;q21) Mucosa-Associated Lymphoid Tissue Lymphoma
Cancer Res.,
May 15, 2004;
64(10):
3452 - 3457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Franco, A. M. Florena, and E. Iannitto
Splenic marginal zone lymphoma
Blood,
April 1, 2003;
101(7):
2464 - 2472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X Mariette
Lymphomas complicating Sjogren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells
Ann Rheum Dis,
November 1, 2001;
60(11):
1007 - 1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Conconi, F. Bertoni, E. Pedrinis, T. Motta, E. Roggero, S. Luminari, C. Capella, M. Bonato, F. Cavalli, and E. Zucca
Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes
Blood,
August 1, 2001;
98(3):
781 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Hernandez, J. L. Garcia, N. C. Gutierrez, M. Mollejo, J. A. Martinez-Climent, T. Flores, M. B. Gonzalez, M. A. Piris, and J. F. San Miguel
Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics
Am. J. Pathol.,
May 1, 2001;
158(5):
1843 - 1850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cavalli, P. G. Isaacson, R. D. Gascoyne, and E. Zucca
MALT Lymphomas
Hematology,
January 1, 2001;
2001(1):
241 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dierlamm, M. Baens, M. Stefanova-Ouzounova, K. Hinz, I. Wlodarska, B. Maes, A. Steyls, A. Driessen, G. Verhoef, P. Gaulard, et al.
Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes
Blood,
September 15, 2000;
96(6):
2215 - 2218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Pandolfino, R. S. Siegel, T. M. Kuzel, S. T. Rosen, and J. Guitart
Primary Cutaneous B-Cell Lymphoma: Review and Current Concepts
J. Clin. Oncol.,
May 10, 2000;
18(10):
2152 - 2168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Baens, B. Maes, A. Steyls, K. Geboes, P. Marynen, and C. De Wolf-Peeters
The Product of the t(11;18), an API2-MLT Fusion, Marks Nearly Half of Gastric MALT Type Lymphomas without Large Cell Proliferation
Am. J. Pathol.,
April 1, 2000;
156(4):
1433 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Berger, P. Felman, C. Thieblemont, T. Pradier, L. Baseggio, P.-A. Bryon, G. Salles, E. Callet-Bauchu, and B. Coiffier
Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients
Blood,
March 15, 2000;
95(6):
1950 - 1956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Callanan, P. Le Baccon, P. Mossuz, S. Duley, C. Bastard, R. Hamoudi, M. J. Dyer, G. Klobeck, R. Rimokh, J. J. Sotto, et al.
The IgG Fc receptor, Fcgamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma
PNAS,
January 4, 2000;
97(1):
309 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rosenwald, G. Ott, S. Stilgenbauer, J. Kalla, M. Bredt, T. Katzenberger, A. Greiner, M. M. Ott, B. Gawin, H. Dohner, et al.
Exclusive Detection of the t(11;18)(q21;q21) in Extranodal Marginal Zone B Cell Lymphomas (MZBL) of MALT Type in Contrast to other MZBL and Extranodal Large B Cell Lymphomas
Am. J. Pathol.,
December 1, 1999;
155(6):
1817 - 1821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dierlamm, M. Baens, I. Wlodarska, M. Stefanova-Ouzounova, J. M. Hernandez, D. K. Hossfeld, C. De Wolf-Peeters, A. Hagemeijer, H. Van den Berghe, and P. Marynen
The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene, MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas
Blood,
June 1, 1999;
93(11):
3601 - 3609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ott, J. Kalla, A. Steinhoff, A. Rosenwald, T. Katzenberger, U. Roblick, M. M. Ott, and H. K. Muller-Hermelink
Trisomy 3 Is Not a Common Feature in Malignant Lymphomas of Mucosa-Associated Lymphoid Tissue Type
Am. J. Pathol.,
September 1, 1998;
153(3):
689 - 694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F.E. Barth, H. Dohner, C. A. Werner, S. Stilgenbauer, M. Schlotter, M. Pawlita, P. Lichter, P. Moller, and M. Bentz
Characteristic Pattern of Chromosomal Gains and Losses in Primary Large B-Cell Lymphomas of the Gastrointestinal Tract
Blood,
June 1, 1998;
91(11):
4321 - 4330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tierens, J. Delabie, S. Pittaluga, A. Driessen, and C. DeWolf-Peeters
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B Lymphocyte Subsets
Blood,
April 1, 1998;
91(7):
2381 - 2386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.G. Willis, I.R. Zalcberg, L.J.A. Coignet, I. Wlodarska, M. Stul, D.M. Jadayel, C. Bastard, J.G. Treleaven, D. Catovsky, M.L.M. Silva, et al.
Molecular Cloning of Translocation t(1;14)(q21;q32) Defines a Novel Gene (BCL9) at Chromosome 1q21
Blood,
March 15, 1998;
91(6):
1873 - 1881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Royer, D. Cazals-Hatem, J. Sibilia, F. Agbalika, J.-M. Cayuela, T. Soussi, F. Maloisel, J.-P. Clauvel, J.-C. Brouet, and X. Mariette
Lymphomas in Patients With Sjogren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses
Blood,
July 15, 1997;
90(2):
766 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|